CS logo
small CS logo
Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)

Gdansk, Pomorskie, Poland

About Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)


During the past decade, Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150) conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)


According to Clinical.Site data, the most researched conditions in "Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Solid Tumors" (1 trials). Many other conditions were trialed in "Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)" in a lesser frequency.

Clinical Trials Intervention Types at Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)


Most popular intervention types in "Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)" are "Drug" (5 trials), "Biological" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "MK-0482" (3 trials), "MK-4830" (3 trials), "Pembrolizumab" (3 trials), "Boserolimab" (2 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)


The vast majority of trials in "Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)" are 7 trials for "All" genders.

Clinical Trials Status at Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)


Currently, there are NaN active trials in "Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150), undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150), 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".